Reversal of New-Onset Type 1 Diabetes in Mice and Induction of FoxP3+ Regulatory T Cells by Syngeneic Bone Marrow Transplantation.

Jian Ouyang,Yanting Wen,Junhao Chen,Yong Liu,De Pei Wu
DOI: https://doi.org/10.1182/blood.v110.11.4857.4857
IF: 20.3
2007-01-01
Blood
Abstract:Objective: Autologous bone marrow transplantation (ABMT) was introduced as a novel strategy to treat new-onset type 1 diabetes (T1D). Induction of CD4+CD25+ FoxP3+T regulatory lymphocytes (Tregs) helps maintain self-tolerance in autoimmune diabetes. Here, we were tying to investigate the effects of syngeneic bone marrow transplantation (syn-BMT) in T1D mice models and to investigate the role of Tregs in this context.
What problem does this paper attempt to address?